The FDA’s expert panel on vaccines voted Thursday to recommend that anyone who gets a primary Covid vaccine going forward ...

After a daylong meeting discussing tentative changes to the nation's COVID-19 vaccine strategy, the FDA's Vaccines and Related Biological Products Advisory Committee voted 21-0 recommending the ...

A panel of experts on Thursday agreed that the bivalent COVID-19 vaccines should be used as both initial and booster shots, ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

a bivalent booster was 48 percent effective against COVID infections caused by XBB.1.5, while it was 52 percent effective ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...

Protecting against Covid infection with the current mRNA technology is unrealistic, a vaccine expert said in a paper ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

Moderna and the Food and Drug Association (FDA) have been accused of concealing data during the approval process for the pharma giant's bivalent Covid booster. Vaccine advisors who signed off on ...

As reported by the FDA, a bivalent vaccine was developed to provide better protection against the omicron variant, and can be referred to as an updated COVID-19 vaccine booster dose. The real ...